This document discusses metabolic liver disease presenting with cholestasis. It begins by defining cholestasis and describing the differences between intrahepatic and extrahepatic cholestasis. In neonates, a metabolic etiology is often the cause of cholestasis and can include conditions like galactosemia or tyrosinemia. The document then examines various etiologies of cholestasis across different age groups. It provides details on progressive familial intrahepatic cholestasis (PFIC), benign recurrent intrahepatic cholestasis (BRIC), and intrahepatic cholestasis of pregnancy. The document emphasizes the importance of early identification of treatable metabolic causes of chole
Metabolic Liver Disease definitions by Dr. Ashish BavdekarSanjeev Kumar
This document discusses metabolic liver disease (MLD), including:
1. MLDs can be classified based on their effects, ranging from no harm to the liver to significant liver injury.
2. Data from Indian hospitals shows MLD cases are increasing and now represent a significant portion of liver diseases seen.
3. MLDs can present early in infancy with features like galactosemia, tyrosinemia, or cystic fibrosis or later with glycogen storage disease, Wilson's disease, or lipid storage disorders.
4. Diagnosing MLD can be challenging due to non-specific signs, genetic heterogeneity, and lack of diagnostic facilities in some areas.
ACUTE LIVER FAILURE - APPROACH AND MANAGEMENTNishant Yadav
Acute liver failure is a clinical syndrome resulting from massive necrosis or impairment of hepatocytes, leaving insufficient liver function. It impairs synthetic, excretory, and detoxifying liver functions. Pediatric acute liver failure is defined by evidence of liver dysfunction within 8 weeks, uncorrectable coagulopathy, and no evidence of chronic liver disease. Causes include viral infections, drugs, and metabolic disorders. Management involves transport to a specialized center, intensive care, supportive care, measures for raised intracranial pressure, coagulopathy, sepsis, and potential liver transplantation.
This document provides an overview of the approach to malabsorption syndrome. It discusses the mechanisms of malabsorption including defects that can occur in the luminal, mucosal, and post-absorptive phases. It describes specific causes of carbohydrate, protein, and fat malabsorption. Clinical manifestations can range from severe steatorrhea and weight loss to subtle changes on labs. The diagnostic approach involves considering malabsorption based on history and physical, confirming with hematological and biochemical tests, and evaluating the underlying cause with tests like imaging, endoscopy, and nutrient absorption tests.
Pediatric Acute Liver Failure (PALF) is defined as evidence of liver dysfunction within 8 weeks of symptoms onset in children, with uncorrectable coagulopathy and no evidence of chronic liver disease. Common etiologies include viral hepatitis, drugs, and other metabolic causes. Diagnostic workup involves general and etiology-specific tests. Key parameters to monitor include encephalopathy grade, coagulopathy, electrolytes, and complications. Treatment focuses on supportive care, complication management, and liver transplantation if indicated based on severity scores. Prognosis depends on etiology and degree of encephalopathy.
The document discusses portal hypertension in children. It covers the anatomy of the portal system, causes/classifications of portal hypertension, clinical manifestations, diagnosis, and treatment. Regarding diagnosis, it describes using endoscopy to identify varices, ultrasound to detect portal vein thrombosis, and CT/MRI/venography to further evaluate vascular anatomy. Treatment of acute variceal bleeding involves stabilizing the patient and reducing portal pressure to stop bleeding.
An inflammatory condition of the pancreas
Acute pancreatitis is a reversible process,
whereas Chronic pancreatitis (CP) is irreversible
Acinar Cell Injury
This case presentation discusses a 7-year-old girl with a history of recurrent abdominal pain diagnosed with chronic pancreatitis. Imaging revealed pancreatic divisum and genetic testing found a CFTR mutation, which is also present in her father who has hereditary pancreatitis. Pancreatic divisum is a congenital anomaly that can cause pancreatitis, especially when accompanied by genetic mutations like CFTR. Management may include enzyme supplementation, monitoring for diabetes, and potentially surgery depending on symptoms. Genetic testing is recommended for recurrent pancreatitis of unknown cause to identify mutations that increase risk.
Metabolic Liver Disease definitions by Dr. Ashish BavdekarSanjeev Kumar
This document discusses metabolic liver disease (MLD), including:
1. MLDs can be classified based on their effects, ranging from no harm to the liver to significant liver injury.
2. Data from Indian hospitals shows MLD cases are increasing and now represent a significant portion of liver diseases seen.
3. MLDs can present early in infancy with features like galactosemia, tyrosinemia, or cystic fibrosis or later with glycogen storage disease, Wilson's disease, or lipid storage disorders.
4. Diagnosing MLD can be challenging due to non-specific signs, genetic heterogeneity, and lack of diagnostic facilities in some areas.
ACUTE LIVER FAILURE - APPROACH AND MANAGEMENTNishant Yadav
Acute liver failure is a clinical syndrome resulting from massive necrosis or impairment of hepatocytes, leaving insufficient liver function. It impairs synthetic, excretory, and detoxifying liver functions. Pediatric acute liver failure is defined by evidence of liver dysfunction within 8 weeks, uncorrectable coagulopathy, and no evidence of chronic liver disease. Causes include viral infections, drugs, and metabolic disorders. Management involves transport to a specialized center, intensive care, supportive care, measures for raised intracranial pressure, coagulopathy, sepsis, and potential liver transplantation.
This document provides an overview of the approach to malabsorption syndrome. It discusses the mechanisms of malabsorption including defects that can occur in the luminal, mucosal, and post-absorptive phases. It describes specific causes of carbohydrate, protein, and fat malabsorption. Clinical manifestations can range from severe steatorrhea and weight loss to subtle changes on labs. The diagnostic approach involves considering malabsorption based on history and physical, confirming with hematological and biochemical tests, and evaluating the underlying cause with tests like imaging, endoscopy, and nutrient absorption tests.
Pediatric Acute Liver Failure (PALF) is defined as evidence of liver dysfunction within 8 weeks of symptoms onset in children, with uncorrectable coagulopathy and no evidence of chronic liver disease. Common etiologies include viral hepatitis, drugs, and other metabolic causes. Diagnostic workup involves general and etiology-specific tests. Key parameters to monitor include encephalopathy grade, coagulopathy, electrolytes, and complications. Treatment focuses on supportive care, complication management, and liver transplantation if indicated based on severity scores. Prognosis depends on etiology and degree of encephalopathy.
The document discusses portal hypertension in children. It covers the anatomy of the portal system, causes/classifications of portal hypertension, clinical manifestations, diagnosis, and treatment. Regarding diagnosis, it describes using endoscopy to identify varices, ultrasound to detect portal vein thrombosis, and CT/MRI/venography to further evaluate vascular anatomy. Treatment of acute variceal bleeding involves stabilizing the patient and reducing portal pressure to stop bleeding.
An inflammatory condition of the pancreas
Acute pancreatitis is a reversible process,
whereas Chronic pancreatitis (CP) is irreversible
Acinar Cell Injury
This case presentation discusses a 7-year-old girl with a history of recurrent abdominal pain diagnosed with chronic pancreatitis. Imaging revealed pancreatic divisum and genetic testing found a CFTR mutation, which is also present in her father who has hereditary pancreatitis. Pancreatic divisum is a congenital anomaly that can cause pancreatitis, especially when accompanied by genetic mutations like CFTR. Management may include enzyme supplementation, monitoring for diabetes, and potentially surgery depending on symptoms. Genetic testing is recommended for recurrent pancreatitis of unknown cause to identify mutations that increase risk.
This document discusses chronic kidney disease (CKD) in pediatrics. It defines CKD as kidney damage lasting at least 3 months as determined by structural abnormalities and/or a glomerular filtration rate below 60 mL/min/1.73m2. The stages of CKD are described based on GFR. Common causes in children include congenital abnormalities and glomerulonephritis. The pathogenesis involves hyperfiltration injury and other factors like proteinuria that accelerate kidney damage. Management aims to address complications through careful monitoring, nutrition, treatment of mineral bone disorders, and controlling blood pressure and electrolyte abnormalities.
Approach to the Patient with Renal DiseasePatrick Carter
This document provides an overview of renal disease for medical students. It defines key terms related to renal function and urine findings. It describes tools for detecting renal disease including history, physical exam, urinalysis, and bloodwork. It discusses uremic syndrome and its effects on multiple organ systems. It differentiates between acute and chronic renal failure, nephritic and nephrotic syndrome based on causes, labs, and physical findings. The goal is to review approaches for evaluating and classifying patients with possible renal disease.
A 45-year-old male presented with jaundice, abdominal distension, and pain. Imaging found intrahepatic biliary radical dilatation and lymphadenopathy. Liver biopsy was recommended to determine the underlying cause of cholestatic jaundice and evaluate for possible malignancy given concerning findings on CT scan and clinical presentation.
various congenital gastrointestinal diseases manifesting in childhood or even in adults, their radiographic findings on various imaging modalities such as radiograph, barium, ultrasound etc.
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by multiple bilateral renal cysts that can lead to kidney failure, with mutations in two genes causing cyst formation through disordered polycystin function; it commonly causes hypertension, pain, infection, and kidney failure and can involve the liver and other organs; management focuses on slowing progression through blood pressure control, pain management, and potentially targeting the renin-angiotensin system or mTOR pathway.
This document discusses several metabolic and inherited liver diseases including hemochromatosis, Wilson's disease, α1-antitrypsin deficiency, and neonatal cholestasis. Hemochromatosis is an inherited disorder caused by excessive iron absorption leading to iron accumulation in tissues like the liver, pancreas and heart. Wilson's disease is a genetic disorder of copper metabolism that results in copper accumulation in tissues including the liver, brain and eyes. α1-antitrypsin deficiency is a genetic condition associated with low levels of α1-antitrypsin protein which can lead to lung and liver disease. Neonatal cholestasis affects 1 in 2500 births and is characterized by prolonged jaundice in infants caused
Cirrhosis is a diffuse process characterized by fibrosis and conversion of liver architecture into abnormal nodules. It is most commonly caused by alcoholism and viral hepatitis. Complications include ascites, portal hypertension, hepatic encephalopathy, and risk of hepatocellular carcinoma. Diagnosis involves blood tests showing liver dysfunction and imaging showing nodular liver. Treatment focuses on managing complications, treating the underlying cause, and liver transplantation for eligible patients. Prognosis is assessed using scoring systems like Child-Pugh and MELD scores.
This document discusses the approach to nephrotic syndrome. It describes the case of a 15-year old male patient presenting with swelling of the face and limbs and decreased urine output. Examinations and investigations revealed nephrotic syndrome. A renal biopsy showed membranoproliferative glomerulonephritis. The document then discusses nephrotic syndrome including definitions, classifications of primary and secondary causes, diagnostic workup including renal biopsy, complications of renal biopsy, and treatment approach.
Evaluation of proteinuria in children pptShane Watson
The document discusses the glomerular filtration barrier and the mechanisms of proteinuria. It defines normal levels of urinary protein excretion in children and describes different types of proteinuria including glomerular, tubular, and overflow proteinuria. Evaluation and workup of asymptomatic proteinuria is outlined including orthostatic testing, urine dipstick, and quantitative urine protein levels. Management depends on the type and severity of proteinuria.
This document discusses gastrointestinal bleeding in children. It notes that GI bleeding accounts for 10-20% of pediatric gastroenterology referrals and around 0.4% of PICU admissions are due to life-threatening GI bleeding. The presentation, classification, causes, diagnostic workup, and treatment of upper and lower GI bleeding in neonates, infants, and children are described in detail over multiple sections. Key points include distinguishing the source and severity of bleeding, identifying specific etiologies, and managing bleeding through supportive care, endoscopic procedures, medications, and surgery as needed.
This document discusses acute-on-chronic liver failure (ACLF). It summarizes the definitions of ACLF provided by various societies/organizations and compares their inclusion/exclusion criteria and timeframes. It describes the progression of cirrhosis and competing risks. Triggers of ACLF decompensation vary globally. The liver failure grading system and AARC model for predicting ACLF outcomes are summarized. Organ dysfunction rather than failure should prompt ACLF diagnosis. Acute variceal bleeding alone does not constitute an acute hepatic insult.
This document discusses the approach to evaluating abdominal pain in children. It outlines several potential causes of acute abdominal pain including appendicitis, intussusception, Henoch-Schönlein purpura, hepatitis, and infant colic. It also discusses recurrent or chronic causes such as Meckel's diverticulum, urolithiasis, testicular torsion, functional dyspepsia, and irritable bowel syndrome. The evaluation of abdominal pain involves considering the child's age, symptoms, physical exam findings, and potentially laboratory or imaging studies to identify serious conditions and determine the appropriate treatment.
This document discusses the various terms used to describe acute liver failure and the evolution of definitions. It begins by covering epidemic hepatitis in the early 20th century and the original use of "fulminant hepatitis". It then discusses later definitions proposed for conditions like fulminant hepatic/liver failure, subfulminant hepatitis/liver failure, and acute/subacute hepatic failure. The document reviews classification systems proposed by various organizations over time to better define and categorize cases based on time of onset of symptoms and hepatic encephalopathy. Overall, it provides historical context on the terminology around acute liver failure.
SYSTEMATIC APPROACH TO LIVER FUNCTION TEST
BY Dr. Navas Shareef. P.P (MBBS)
THIS PRESENTATION IS MADE IN A SIMPLIFIED FORM SO THAT EVERYONE COULD UNDERSTAND ABOUT A LIVER FUNCTION TEST EASILY
1) Acute-on-chronic liver failure (ACLF) describes acute deterioration of liver function in patients with previously stable chronic liver disease, due to a precipitating event.
2) The Asian Pacific Association for the Study of the Liver defined ACLF as acute hepatic insult (jaundice and coagulopathy) within 4 weeks of ascites and/or encephalopathy in patients with chronic liver disease.
3) Pathogenesis involves systemic inflammatory response, neutrophil dysfunction, circulatory changes, oxidative stress, and circulating toxins that further damage the liver and impair regeneration.
- Acute liver failure in children is rare but has a different pathology than in adults. It can be difficult to diagnose, especially in infants, and definitions and management strategies have historically been borrowed from adult experiences.
- There are different types of acute liver failure including those with and without underlying liver diseases. Prognostic indicators beyond just encephalopathy are needed to determine transplant listing.
- New approaches such as auxiliary liver transplants, hepatocyte transplants, and extracorporeal assist devices show promise as bridges to recovery in acute liver failure in children. Early referral to specialized centers is important.
The document provides an outline for pathology lectures on nephrotic syndrome, nephritic syndrome, rapidly progressive glomerulonephritis (RPGN), and chronic kidney disease (CKD). It discusses the objectives, key topics, and clinical manifestations of these conditions. It then focuses on RPGN/crescentic glomerulonephritis, describing the types (I-III) based on etiology, light microscopy findings, and clinical features. Finally, it covers CKD/CRF, discussing common causes, clinical features, and morphology under light microscopy of end-stage kidneys.
Acute renal failure is a clinical syndrome where sudden deterioration of renal function results in the kidneys' inability to maintain fluid and electrolyte homeostasis. It has various etiologies like pre-renal, intrinsic renal, and post-renal factors. Management involves treating the underlying cause, fluid resuscitation, controlling electrolyte abnormalities, and starting dialysis for refractory volume overload, hyperkalemia, acidosis, or neurological symptoms. The healthcare team works to stabilize the patient and prevent long-term kidney damage.
This document discusses tubulo-interstitial pathology and chronic glomerulonephritis. It defines acute pyelonephritis, its causes and morphology. It describes chronic pyelonephritis and reflux nephropathy, including forms of chronic pyelonephritis and their gross and microscopic morphology. It also discusses drug-induced tubulo-interstitial nephritis, analgesic nephropathy, causes of chronic glomerulonephritis, and interpreting morphology of chronic glomerulonephritis.
Hbs ag positive in special situation dr. prarthana kalgaonkarSanjeev Kumar
This document summarizes a case study of a 10-year-old female patient presenting with fever, jaundice, and cough for several days. Medical history revealed the patient had Hodgkin's disease in 2009 and completed chemotherapy in 2010. Current tests showed hepatitis B infection, pleural effusion secondary to tuberculosis, and possible relapse of Hodgkin's disease. A liver biopsy supported Hodgkin's lymphoma involvement. The patient has hepatitis B infection complicated by a relapse of Hodgkin's disease and disseminated tuberculosis.
This document discusses chronic kidney disease (CKD) in pediatrics. It defines CKD as kidney damage lasting at least 3 months as determined by structural abnormalities and/or a glomerular filtration rate below 60 mL/min/1.73m2. The stages of CKD are described based on GFR. Common causes in children include congenital abnormalities and glomerulonephritis. The pathogenesis involves hyperfiltration injury and other factors like proteinuria that accelerate kidney damage. Management aims to address complications through careful monitoring, nutrition, treatment of mineral bone disorders, and controlling blood pressure and electrolyte abnormalities.
Approach to the Patient with Renal DiseasePatrick Carter
This document provides an overview of renal disease for medical students. It defines key terms related to renal function and urine findings. It describes tools for detecting renal disease including history, physical exam, urinalysis, and bloodwork. It discusses uremic syndrome and its effects on multiple organ systems. It differentiates between acute and chronic renal failure, nephritic and nephrotic syndrome based on causes, labs, and physical findings. The goal is to review approaches for evaluating and classifying patients with possible renal disease.
A 45-year-old male presented with jaundice, abdominal distension, and pain. Imaging found intrahepatic biliary radical dilatation and lymphadenopathy. Liver biopsy was recommended to determine the underlying cause of cholestatic jaundice and evaluate for possible malignancy given concerning findings on CT scan and clinical presentation.
various congenital gastrointestinal diseases manifesting in childhood or even in adults, their radiographic findings on various imaging modalities such as radiograph, barium, ultrasound etc.
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by multiple bilateral renal cysts that can lead to kidney failure, with mutations in two genes causing cyst formation through disordered polycystin function; it commonly causes hypertension, pain, infection, and kidney failure and can involve the liver and other organs; management focuses on slowing progression through blood pressure control, pain management, and potentially targeting the renin-angiotensin system or mTOR pathway.
This document discusses several metabolic and inherited liver diseases including hemochromatosis, Wilson's disease, α1-antitrypsin deficiency, and neonatal cholestasis. Hemochromatosis is an inherited disorder caused by excessive iron absorption leading to iron accumulation in tissues like the liver, pancreas and heart. Wilson's disease is a genetic disorder of copper metabolism that results in copper accumulation in tissues including the liver, brain and eyes. α1-antitrypsin deficiency is a genetic condition associated with low levels of α1-antitrypsin protein which can lead to lung and liver disease. Neonatal cholestasis affects 1 in 2500 births and is characterized by prolonged jaundice in infants caused
Cirrhosis is a diffuse process characterized by fibrosis and conversion of liver architecture into abnormal nodules. It is most commonly caused by alcoholism and viral hepatitis. Complications include ascites, portal hypertension, hepatic encephalopathy, and risk of hepatocellular carcinoma. Diagnosis involves blood tests showing liver dysfunction and imaging showing nodular liver. Treatment focuses on managing complications, treating the underlying cause, and liver transplantation for eligible patients. Prognosis is assessed using scoring systems like Child-Pugh and MELD scores.
This document discusses the approach to nephrotic syndrome. It describes the case of a 15-year old male patient presenting with swelling of the face and limbs and decreased urine output. Examinations and investigations revealed nephrotic syndrome. A renal biopsy showed membranoproliferative glomerulonephritis. The document then discusses nephrotic syndrome including definitions, classifications of primary and secondary causes, diagnostic workup including renal biopsy, complications of renal biopsy, and treatment approach.
Evaluation of proteinuria in children pptShane Watson
The document discusses the glomerular filtration barrier and the mechanisms of proteinuria. It defines normal levels of urinary protein excretion in children and describes different types of proteinuria including glomerular, tubular, and overflow proteinuria. Evaluation and workup of asymptomatic proteinuria is outlined including orthostatic testing, urine dipstick, and quantitative urine protein levels. Management depends on the type and severity of proteinuria.
This document discusses gastrointestinal bleeding in children. It notes that GI bleeding accounts for 10-20% of pediatric gastroenterology referrals and around 0.4% of PICU admissions are due to life-threatening GI bleeding. The presentation, classification, causes, diagnostic workup, and treatment of upper and lower GI bleeding in neonates, infants, and children are described in detail over multiple sections. Key points include distinguishing the source and severity of bleeding, identifying specific etiologies, and managing bleeding through supportive care, endoscopic procedures, medications, and surgery as needed.
This document discusses acute-on-chronic liver failure (ACLF). It summarizes the definitions of ACLF provided by various societies/organizations and compares their inclusion/exclusion criteria and timeframes. It describes the progression of cirrhosis and competing risks. Triggers of ACLF decompensation vary globally. The liver failure grading system and AARC model for predicting ACLF outcomes are summarized. Organ dysfunction rather than failure should prompt ACLF diagnosis. Acute variceal bleeding alone does not constitute an acute hepatic insult.
This document discusses the approach to evaluating abdominal pain in children. It outlines several potential causes of acute abdominal pain including appendicitis, intussusception, Henoch-Schönlein purpura, hepatitis, and infant colic. It also discusses recurrent or chronic causes such as Meckel's diverticulum, urolithiasis, testicular torsion, functional dyspepsia, and irritable bowel syndrome. The evaluation of abdominal pain involves considering the child's age, symptoms, physical exam findings, and potentially laboratory or imaging studies to identify serious conditions and determine the appropriate treatment.
This document discusses the various terms used to describe acute liver failure and the evolution of definitions. It begins by covering epidemic hepatitis in the early 20th century and the original use of "fulminant hepatitis". It then discusses later definitions proposed for conditions like fulminant hepatic/liver failure, subfulminant hepatitis/liver failure, and acute/subacute hepatic failure. The document reviews classification systems proposed by various organizations over time to better define and categorize cases based on time of onset of symptoms and hepatic encephalopathy. Overall, it provides historical context on the terminology around acute liver failure.
SYSTEMATIC APPROACH TO LIVER FUNCTION TEST
BY Dr. Navas Shareef. P.P (MBBS)
THIS PRESENTATION IS MADE IN A SIMPLIFIED FORM SO THAT EVERYONE COULD UNDERSTAND ABOUT A LIVER FUNCTION TEST EASILY
1) Acute-on-chronic liver failure (ACLF) describes acute deterioration of liver function in patients with previously stable chronic liver disease, due to a precipitating event.
2) The Asian Pacific Association for the Study of the Liver defined ACLF as acute hepatic insult (jaundice and coagulopathy) within 4 weeks of ascites and/or encephalopathy in patients with chronic liver disease.
3) Pathogenesis involves systemic inflammatory response, neutrophil dysfunction, circulatory changes, oxidative stress, and circulating toxins that further damage the liver and impair regeneration.
- Acute liver failure in children is rare but has a different pathology than in adults. It can be difficult to diagnose, especially in infants, and definitions and management strategies have historically been borrowed from adult experiences.
- There are different types of acute liver failure including those with and without underlying liver diseases. Prognostic indicators beyond just encephalopathy are needed to determine transplant listing.
- New approaches such as auxiliary liver transplants, hepatocyte transplants, and extracorporeal assist devices show promise as bridges to recovery in acute liver failure in children. Early referral to specialized centers is important.
The document provides an outline for pathology lectures on nephrotic syndrome, nephritic syndrome, rapidly progressive glomerulonephritis (RPGN), and chronic kidney disease (CKD). It discusses the objectives, key topics, and clinical manifestations of these conditions. It then focuses on RPGN/crescentic glomerulonephritis, describing the types (I-III) based on etiology, light microscopy findings, and clinical features. Finally, it covers CKD/CRF, discussing common causes, clinical features, and morphology under light microscopy of end-stage kidneys.
Acute renal failure is a clinical syndrome where sudden deterioration of renal function results in the kidneys' inability to maintain fluid and electrolyte homeostasis. It has various etiologies like pre-renal, intrinsic renal, and post-renal factors. Management involves treating the underlying cause, fluid resuscitation, controlling electrolyte abnormalities, and starting dialysis for refractory volume overload, hyperkalemia, acidosis, or neurological symptoms. The healthcare team works to stabilize the patient and prevent long-term kidney damage.
This document discusses tubulo-interstitial pathology and chronic glomerulonephritis. It defines acute pyelonephritis, its causes and morphology. It describes chronic pyelonephritis and reflux nephropathy, including forms of chronic pyelonephritis and their gross and microscopic morphology. It also discusses drug-induced tubulo-interstitial nephritis, analgesic nephropathy, causes of chronic glomerulonephritis, and interpreting morphology of chronic glomerulonephritis.
Hbs ag positive in special situation dr. prarthana kalgaonkarSanjeev Kumar
This document summarizes a case study of a 10-year-old female patient presenting with fever, jaundice, and cough for several days. Medical history revealed the patient had Hodgkin's disease in 2009 and completed chemotherapy in 2010. Current tests showed hepatitis B infection, pleural effusion secondary to tuberculosis, and possible relapse of Hodgkin's disease. A liver biopsy supported Hodgkin's lymphoma involvement. The patient has hepatitis B infection complicated by a relapse of Hodgkin's disease and disseminated tuberculosis.
Hepatitis b in children dr. anshu srivastavaSanjeev Kumar
- A study from India found hepatitis B surface antigen (HBsAg) prevalence rates in children aged 0-14 years ranged from 2.1-6.1%, depending on age, showing India has intermediate endemicity for HBV.
- HBV infection in children can be asymptomatic, cause acute hepatitis, chronic liver disease, or hepatocellular carcinoma. Perinatal transmission accounts for 40-50% of cases in children.
- Evaluation of chronic HBV involves assessing HBeAg, HBV DNA levels, liver enzymes and histology to determine phase of infection and need for treatment. Treatment goals are sustained suppression of HBV DNA and remission of liver disease.
Protocol based approach to metabolic liver disease seema alamSanjeev Kumar
This document outlines a protocol-based approach to identifying metabolic liver disease (MLD) as the cause of unexplained liver conditions in children. Key points include:
- MLD accounts for a significant percentage of pediatric liver disease cases that were previously classified as cryptogenic or of unknown etiology.
- The most common presentation of MLD is organomegaly.
- Following a series of diagnostic protocols tailored to different clinical presentations can help detect many treatable or palliative MLD cases that may otherwise go undiagnosed.
- Applying these protocols at a large pediatric liver disease center in India reduced the percentage of cases classified as cryptogenic or indeterminate from over 25% to under
Farnesoid x receptor (fxr) and intestinal mucosa - Stefano FiorucciAttività scientifica
Bile acids activated receptors regulate the integrity of gastrointestinal mucosafocus on FXR.
Stefano Fiorucci,
MD Department of Surgical and Biomedical Sciences
University of Perugia
For The Japanese Society of Gastroenterology (JSGE) COI Disclosure
The patient presented with fever, progressive pallor, weakness, nosebleeds, enlarged liver, prolonged blood clotting time, and increased liver enzymes. Her condition deteriorated despite treatment and she developed urinary incontinence, low blood pressure, fixed and dilated pupils, and went into cardiac arrest. Liver biopsy surprisingly found no evidence of infection but showed fatty changes. This led to the diagnosis of Reye's syndrome, a rare condition causing liver and brain damage from mitochondrial dysfunction following a viral infection.
This document discusses how to diagnose the cause of jaundice through taking a history, performing an examination, and ordering special tests. It outlines various causes of jaundice such as increased bilirubin load from conditions like hereditary spherocytosis or hepatitis, disturbed bilirubin uptake from viral hepatitis or drugs, and disturbed bilirubin excretion from gallstones, cirrhosis, or pancreatic cancer. The examination involves assessing a patient's general appearance, abdomen, liver, and spleen to identify signs that can indicate the cause of jaundice. Special tests are also needed to make an accurate diagnosis.
Hepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meenaSanjeev Kumar
Case: Hepatomegaly with seizures and hepatitis in a family
Presenter: Rajesh Kumar Meena
Moderator: Vidyut Bhatia
Panelists: Seema Alam, Alka Jadhav, Anshu Srivastava
11 yr old with a fatty liver dr. shilpa hegdeSanjeev Kumar
A 11-year-old boy presented with a history of abdominal pain, obesity, and a family history of diabetes. Physical examination found hepatomegaly, acanthosis nigricans, and hypertension. Laboratory tests showed elevated liver enzymes, insulin resistance, and dyslipidemia. Ultrasound found grade 1 fatty liver. He was diagnosed with non-alcoholic fatty liver disease associated with features of metabolic syndrome likely due to obesity, poor diet, and sedentary lifestyle. Management involved lifestyle modifications including diet, exercise and monitoring for progression of liver disease or other metabolic complications.
Wilson’s disease – how do i manage dr. ashish bavdekarSanjeev Kumar
Wilson's disease is managed through a combination of medications, diet, and monitoring. Key treatments include chelating agents like penicillamine and trientine to reduce copper levels, as well as zinc supplements which induce metallothionein. Patients require lifelong therapy to maintain a negative copper balance and regular monitoring of clinical symptoms and biochemical markers like urinary copper to assess treatment response and detect non-compliance or side effects.
Child with acute liver failure dr. kirtichandra kodaliSanjeev Kumar
A 3-year-old boy presented with fever, cough, loose stools and increasing drowsiness over the past few days. On examination, he showed signs of dehydration and liver enlargement. Laboratory tests found elevated liver enzymes and ammonia levels, indicating acute liver failure. The cause was determined to be paracetamol toxicity from an accidental overdose, as serum paracetamol levels were found to be toxic. The patient was treated with N-acetyl cysteine and supportive care, and his condition improved such that his liver function normalized and he was discharged.
1) A 5-year-old boy presented with hepatomegaly since birth and two seizures at age 1.5 years. Initial investigations showed elevated liver enzymes.
2) Liver biopsy found hepatocytes swollen with pale cytoplasm and intracytoplasmic glycogen, consistent with a glycogen storage disease.
3) The diagnosis was determined to be a glycogen storage disease based on the clinical features of hepatomegaly, seizures, and pathological findings on liver biopsy. Management involved dietary advice and monitoring of liver and metabolic parameters.
Common drug induced liver injury in children -dr. harshad devarbhaiSanjeev Kumar
This document discusses common drug-induced liver injury in children. It presents two case studies of pediatric patients who developed acute liver failure after receiving multiple drug treatments. Liver enzyme levels increased dramatically in both patients, and one child died of hyperacute liver failure while the other died shortly after admission. The document reviews the challenges of pediatric drug-induced liver injury given differences in drug metabolism and formulations in children. Common culprit drugs identified are antituberculosis medications, acetaminophen, and anti-epileptic drugs. Younger age is a risk factor for valproate hepatotoxicity. Prompt identification and discontinuation of the offending drug is important to prevent serious outcomes like acute liver failure.
Interpret tests for metabolic diseases talk sk yachhaSanjeev Kumar
Clinical suspicion of inborn errors of metabolism should arise with parental consanguinity, positive family history, unexplained sibling deaths, or recurrent issues like hypoglycemia, acidosis, or encephalopathy. Initial screening tests available in India can help identify aminoaciduria, organic acidemias, or fatty acid oxidation defects while definitive testing requires samples not readily available, like fresh tissue, to analyze specific enzyme activities. Managing treatable conditions like hereditary fructose intolerance or some organic acidemias can improve outcomes.
The document provides an overview of hematology and the components of blood. It discusses the composition of plasma and formed elements such as red blood cells, white blood cells, and platelets. It then focuses on red blood cells, describing their structure, production, regulation, and turnover. Various types of anemia are summarized, including microcytic hypochromic anemia caused by iron deficiency or thalassemia, macrocytic anemia related to B12 or folate deficiency, and hemolytic anemias like spherocytosis and sickle cell disease. Peripheral smears and diagnostic tests for different anemias are also reviewed.
This document discusses direct hyperbilirubinemia and neonatal cholestasis. It defines direct hyperbilirubinemia as a serum direct/conjugated bilirubin concentration greater than thresholds based on the total serum bilirubin level. Neonatal cholestasis is defined as conjugated hyperbilirubinemia in newborns resulting from diminished bile flow. Causes include intrahepatic and extrahepatic etiologies like biliary atresia. The document provides details on clinical presentation, investigations, management, and treatment of various conditions that can cause neonatal cholestasis.
This document summarizes cirrhosis of the liver. It defines cirrhosis as irreversible liver damage characterized by abnormal liver structure and function. The main causes listed are chronic alcohol abuse, hepatitis B and C, non-alcoholic steatohepatitis (NASH), and genetic disorders. Complications include hepatic failure, portal hypertension, ascites, variceal bleeding, and hepatocellular carcinoma. Tests used to diagnose and monitor cirrhosis are also outlined. Management focuses on treating the underlying cause, nutrition, screening for complications, and liver transplantation in severe cases.
This document discusses direct jaundice and neonatal cholestasis. It begins by defining direct jaundice and noting that it indicates cholestasis and hepatobiliary dysfunction. The causes of neonatal cholestasis are then outlined, including extrahepatic (e.g. biliary atresia), intrahepatic (e.g. PFIC), and hepatocellular disorders (e.g. metabolic and infections). The diagnostic evaluation, management, and specific conditions like biliary atresia and choledochal cyst are then reviewed over multiple sections.
Diagnosis & Management of Chronic Liver Disease.pptKhooChunYik
The document provides information on chronic liver disease and its management. It discusses the anatomy and functions of the liver, definitions and types of cirrhosis, complications including portal hypertension, hepatic encephalopathy, and spontaneous bacterial peritonitis. Investigations covered include blood tests, imaging, and liver biopsy. Management of acute complications involves treatment of ascites, bleeding, and infections. Chronic management focuses on abstaining from alcohol, optimizing nutrition, and treating complications through medication and procedures like TIPSS. Prognosis depends on severity and treatment response.
This document discusses neonatal cholestasis, defined as conjugated hyperbilirubinemia developing within the first 90 days of life. It outlines the differential diagnosis and evaluation of neonatal cholestasis, distinguishing between extrahepatic and intrahepatic etiologies. Key tests and management strategies are described for different conditions, including nutritional support, treatment of symptoms, and surgical or transplant options for certain etiologies like biliary atresia.
This patient, an 80-year-old African American female, presented with persistent jaundice for 2 months following a laparoscopic cholecystectomy for gallstones. Her jaundice initially decreased after surgery but returned, and she now has itching and tea-colored urine. Her weight has decreased 30 pounds over the past year despite good appetite. Physical exam showed jaundice but no signs of chronic liver disease. CT scan found nondilated bile ducts. The persistent jaundice following cholecystectomy suggests an underlying cause needs to be identified.
This document provides an overview of jaundice and its causes. It defines jaundice as a yellowish discoloration of the skin and eyes. Jaundice can be classified as pre-hepatic (haemolytic), hepatocellular, or obstructive based on its underlying mechanism. Common causes discussed include viral hepatitis, alcoholic liver disease, gallstones, and tumors. The document outlines approaches to evaluating a jaundiced patient through history, examination, and laboratory and imaging tests. It also describes treatment principles and specific therapies for acute viral hepatitis and liver failure.
Obstructive jaundice is a dangerous form of disease. It is invariably treated medically leading to a delay in diagnosing the surgical cause. Prompt multipronged approach is therefore essential for early diagnosis.
1) Neonatal cholestasis is defined as conjugated hyperbilirubinemia in newborns caused by diminished bile flow. The document discusses the definition, epidemiology, etiologies, clinical presentation, investigations and management of neonatal cholestasis.
2) The causes of neonatal cholestasis include intrahepatic causes like infections, metabolic disorders, and extrahepatic causes like biliary atresia and choledochal cysts. The most common causes of cholestasis in the first month are biliary atresia and neonatal hepatitis.
3) Evaluation involves history, physical exam, initial lab tests and further tests depending on the findings. Imaging like ultrasound
Thank you for explaining the process. I will be sure to follow the mark scheme closely when consenting patients. Effective communication is so important to ensure informed consent.
This document discusses neonatal cholestasis syndrome, including its definition, incidence, etiology, and management. It defines neonatal cholestasis as prolonged elevation of conjugated bilirubin beyond the first 14 days of life. The incidence is reported to be 1 in 2500 live births in western countries and hepatocellular causes account for 45-69% of cases in India. The document describes various etiologies of cholestasis including biliary atresia, metabolic disorders, infections and discusses approaches to diagnosis and treatment including laboratory tests, imaging, biopsy and surgical interventions like Kasai procedure or liver transplantation.
The document provides an overview of liver function tests (LFTs), including their use, limitations, classification, and interpretation. Some key points:
- LFTs evaluate liver biochemistry and injury but cannot detect overall liver function. Clinical history is most important.
- Tests evaluate transport, injury, cholestasis, synthetic function, and substances cleared by the liver.
- Elevated enzymes like ALT/AST indicate liver cell injury while alkaline phosphatase and GGT indicate cholestasis. Albumin and PT assess synthetic function.
- LFTs can screen for disease, assess severity, and monitor treatment response but lack full sensitivity and specificity. Clinical context is critical for interpretation.
Neonatal cholestasis is defined as prolonged elevation of conjugated bilirubin beyond the first 14 days of life. It can be caused by defects in intrahepatic bile production, bile transport, or bile flow obstruction. The document discusses the etiology, clinical presentation, evaluation, and management of neonatal cholestasis. Key tests include liver enzymes, genetic testing, imaging, and liver biopsy. Biliary atresia and neonatal hepatitis are the most common causes and require different treatment approaches. The Kasai procedure is the surgical treatment for biliary atresia but transplantation may eventually be needed in most cases.
Chronic liver disease in children22.pptxAmmaraHameed6
This document discusses chronic liver disease and portal hypertension in children. It defines chronic liver disease as ongoing liver injury for at least 6 months that can progress to cirrhosis and liver failure. Cirrhosis is the end result of liver cell damage and destruction. The etiology of chronic liver disease in children varies according to age and includes infectious, metabolic, autoimmune, anatomical, and toxic/drug-induced causes. Some common chronic liver diseases in children discussed in detail include biliary atresia, alpha-1 antitrypsin deficiency, cystic fibrosis, and Wilson's disease.
This document provides an overview of jaundice and its evaluation. It defines jaundice and discusses serum bilirubin levels. It covers the bilirubin production and metabolism pathways. It describes the classification of jaundice by etiology, bilirubin type, and site of disease. Key investigations for evaluating a patient with jaundice are outlined. Important aspects of history taking and clinical examination are highlighted.
MLD presenting with ALF Talk by Dr SK YachhaSanjeev Kumar
Metabolic disorders are a common cause of acute liver failure (ALF) in infants and children. Several key metabolic disorders that can cause ALF include neonatal hemochromatosis, type 1 tyrosinemia, mitochondrial cytopathies such as fatty acid oxidation defects and respiratory chain disorders, galactosemia, and urea cycle defects. Timely diagnosis and specific treatment of the underlying metabolic etiology are important for improving outcomes in pediatric ALF.
1. Neonatal cholestasis is defined as conjugated hyperbilirubinemia in a newborn. It can be caused by intrahepatic or extrahepatic conditions.
2. Common etiologies include biliary atresia, metabolic diseases like galactosemia, and infections. Biliary atresia is the most common cause of extrahepatic cholestasis.
3. Evaluation involves history, physical exam, lab tests including liver function tests and imaging, and may require liver biopsy. Treatment depends on the underlying cause but may include surgical intervention or lifestyle changes.
A 80-year-old African American female presents with 2 months of jaundice. She had her gallbladder removed 2 months ago for gallstones but the jaundice did not fully resolve. Her examination shows jaundice and she reports tea-colored urine for 1 month. CT scan found nondilated bile ducts. The persistent jaundice after cholecystectomy suggests another cause of obstruction or underlying liver disease may be present.
This document discusses jaundice and hyperbilirubinemia. It defines jaundice as a yellow discoloration from bile pigment deposition. Jaundice can be detected when serum bilirubin is above 2-2.5 mg/dL. Bilirubin is produced from the breakdown of hemoglobin and exists in unconjugated and conjugated forms. Elevated bilirubin can be caused by overproduction, impaired hepatic uptake or excretion, or biliary obstruction. Evaluation involves liver and biliary imaging and lab tests of liver and biliary function. Stable patients may be discharged with follow up, while those with signs of failure or obstruction typically need admission.
Similar to Metabolic liver disease presenting with cholestasis talk anshu srivastava (20)
1. An 8-year-old male presented with resistant rickets and bony deformities. Initial workup found hypocalcemia, hypophosphatemia, elevated alkaline phosphatase, and normal parathyroid hormone.
2. Further testing revealed proximal renal tubular acidosis, hypokalemia, and firm hepatomegaly. Wilson's disease was suspected and confirmed with elevated urinary copper levels.
3. The patient was diagnosed with Wilson's disease presenting as resistant rickets and proximal renal tubular acidosis. He was started on chelating agents and potassium citrate to treat the Wilson's disease and renal tubular acidosis respectively.
Wilson Disease - Beyond the liver and brain…- Dr Ujjal PoddarSanjeev Kumar
This document discusses the non-hepatic and non-neurological manifestations of Wilson's disease. It summarizes several studies that found the majority of Wilson's disease patients presented with hepatic or neurological symptoms, while a minority exhibited other manifestations. These included bone, joint, eye, heart, blood, kidney, skin and endocrine issues. Specifically, it notes that bone and joint pain can be early presenting symptoms and unexplained hemolysis in young adults should raise suspicion for Wilson's disease screening. The document concludes that while uncommon, recognition of non-hepatic manifestations is important for fully characterizing and managing Wilson's disease.
This document discusses the role of liver biopsy in determining the stage and cause of liver disease. A liver biopsy can reveal the stage of disease, whether it is caused by autoimmune, metabolic, or viral factors. Early stage disease may show minor changes like mild steatosis, while later stages show features like portal inflammation, interface hepatitis, steatosis, glycogenated nuclei, Mallory bodies, and copper accumulation. Copper stains on biopsy tissue can help determine if Wilson's disease is present, shown by red-orange or black-brown copper deposits. The document also describes several case examples where liver biopsy aided in diagnosis, such as diagnosing Wilson's disease in an 8-year old male based on cirrhosis and
Key publications on wilson disease in last 3 yearsSanjeev Kumar
This document summarizes key publications on Wilson disease from the last 3 years. It discusses clinical profiles of Wilson disease patients, patient and graft survival rates post-liver transplantation, issues with immunosuppressive regimens post-transplant, and experimental adenoviral gene therapy providing long-term correction of copper metabolism in a mouse model of Wilson disease. It also presents studies finding that increased levels of non-ceruloplasmin bound and exchangeable copper are associated with oxidative stress and neurological worsening in Wilson disease patients.
This document summarizes a case discussion of a 10-year-old female patient presenting with acute liver failure and hemolysis who was potentially in need of a liver transplant. The patient had symptoms for 4 weeks and was initially evaluated at a nearby hospital before being referred for further evaluation. On examination, she had pallor, icterus, periorbital puffiness, distended abdomen, and enlarged liver and spleen. Investigations showed abnormal liver function tests and signs of hemolysis. Based on further testing, she was diagnosed with Wilson's disease. Due to developing grade 2 encephalopathy, she underwent living-related liver transplantation with her mother as the donor. She recovered well after the transplant.
When does one use zinc alone - Dr Vinay GoyalSanjeev Kumar
This document discusses the use of zinc alone in treating Wilson's disease. Zinc is the preferred initial treatment as it is nontoxic and prevents copper absorption in the intestine. It works by inducing intestinal metallothionein and blocking copper absorption and resorption from the gastrointestinal tract. Zinc can be used long-term for maintenance therapy in Wilson's disease patients, including during pregnancy where it has been shown to be safe. The document also discusses combinations of zinc and penicillamine, noting some studies have found higher mortality with this combination compared to other therapies.
The panel discussion focused on developmental, speech, psychiatric and counseling issues related to Wilson's disease. The panelists were experts in neurology, speech pathology, psychiatry and counseling. Key topics discussed included:
- Common neurological and psychiatric manifestations of Wilson's disease including movement disorders, dysarthria, and behavioral/mood changes.
- The importance of considering Wilson's disease in young patients presenting with recent neuropsychiatric symptoms that are treatment resistant.
- Challenges in diagnosing and managing dominant psychiatric presentations of Wilson's disease.
- The role of various specialists like speech therapists and counselors in addressing issues related to speech, behavior, rehabilitation and quality of life in patients with Wilson's
Hepatic and Neuro Wilson disease - Is there a difference? - Dr John MatthaiSanjeev Kumar
This document discusses the differences between hepatic and neurological involvement in Wilson disease. It notes that the pathophysiology of how copper overload leads to liver vs. brain disease is not fully understood. The document then lists several clinical observations that may provide clues about the pathophysiology: 1) Not all copper overload syndromes affect both the liver and brain. 2) Neurological disease can sometimes occur without liver involvement in Wilson disease patients. 3) Copper chelating treatments can improve both liver and neurological symptoms.
Diagnostic challenges in Wilson disease: do scoring systems help? - Dr Harsha...Sanjeev Kumar
This document discusses diagnostic challenges in Wilson disease and whether scoring systems help. It summarizes that experts view hepatic and neuropsychiatric Wilson disease differently. It then discusses several prognostic scoring systems used for acute liver failure, including Child-Pugh, MELD, and Nazer scores. Data is presented on etiologies of acute liver failure from studies in India. Scoring systems for Wilson disease are also discussed, noting they have variable sensitivity and many patients who died could not undergo testing. The take home message is that appropriate combinations of symptoms, signs, and screening tests are usually adequate for diagnosis, and the main challenge is considering Wilson disease initially.
Panel Discussion - Genetics - Is there a role in clinical practice? - Dr Seem...Sanjeev Kumar
Genetic testing plays an important role in the diagnosis and management of Wilson disease (WD), though it cannot replace standard biochemical tests. In the presented cases:
1) Genetic testing confirmed diagnosis in a child with classic WD, and showed that a negative result did not rule out WD given genetic heterogeneity.
2) It was useful for family screening and managing a fulminant case.
3) It was the preferred method for screening asymptomatic siblings.
4) While it did not replace liver biopsy, it provided additional information in inconclusive cases.
5) Treatment should not be based on genetic results alone without biochemical abnormalities.
Genetic counseling was recommended for families planning pregnancy due
Choice and Monitoring of drug therapy - Dr Ashish BavdekarSanjeev Kumar
Wilson's disease is treated with chelating agents like penicillamine or trientine to reduce copper levels over 6-12 months. Zinc is used long-term to maintain a negative copper balance. Patients require lifelong monitoring clinically and through liver enzymes and urinary/serum copper levels to determine treatment effectiveness, compliance, and adverse effects. Biochemical improvement can take variable times from months to years.
Copper in health and disease - Dr Srinivas SankaranarayananSanjeev Kumar
Copper is an essential trace element that plays an important role in many biological processes as a co-factor in enzymes. Both copper deficiency and toxicity can cause disease. Copper homeostasis is tightly regulated in the body by transport proteins like ATP7A and ATP7B, as free copper above certain levels can be toxic. Genetic mutations in ATP7B can cause Wilson's disease, characterized by copper accumulation in tissues. While Indian Childhood Cirrhosis was once thought to be caused by excess copper intake, it has disappeared as copper utensils were replaced, suggesting other etiologies. There is increasing evidence for the role of copper in neurodegenerative diseases like Alzheimer's through oxidative stress mechanisms.
Why did d-penicillamine disappear from the market?Sanjeev Kumar
This document summarizes a talk on the shortage of the drug penicillamine in India. It discusses that penicillamine disappeared from the market in mid-2016 due to lack of raw material supply from China. The official reason was that the raw material supplier was unavailable, but the actual reasons may have been that the drug came under price control and suppliers did not want to provide raw materials at a competitive price. It also discusses the roles of the Central Drugs Standard Control Organization and National Pharmaceutical Pricing Authority in regulating drug prices and availability in India. The real issue highlighted is India's increasing dependence on China for drug ingredients and the need to support domestic bulk drug manufacturing.
Role of MRI in Wilson disease - Dr Sanjib SinhaSanjeev Kumar
Wilson's disease is a rare genetic disorder that causes copper to accumulate in the brain and other vital organs. MRI plays an important role in evaluating patients with suspected Wilson's disease. Key findings on MRI include signal changes in the basal ganglia, midbrain, pons, and cerebral white matter. Characteristic signs include T1 hyperintensity of the globus pallidus, the "face of the giant panda" sign, and CPM-like changes resembling osmotic demyelination. Serial MRI can show improvement in many patients responding to treatment, while extensive changes correlate with poorer prognosis. Advanced techniques like DTI reveal more widespread white matter abnormalities than conventional MRI and help assess disease severity.
Complications of drug therapy - Dr Malathi SathiyasekaranSanjeev Kumar
1) The document discusses various drug therapies for Wilson disease including penicillamine, zinc, trientine, and tetrathiomolybdate.
2) Penicillamine has severe side effects in 30% of patients including kidney toxicity, lupus-like syndrome, and bone marrow suppression. Its complications can be both direct chemical toxicity or immune-mediated.
3) Zinc has very few side effects but can cause gastric irritation. It is less likely than other drugs to cause neurological deterioration.
How do we monitor neurological improvement - Dr Rukmini MridulaSanjeev Kumar
This document discusses monitoring neurological improvement in patients with Wilson's disease undergoing treatment. It outlines several scales that can be used to stage and monitor patients, including the Chu staging scale and the Global Assessment Scale for Wilson's Disease. When monitoring therapy, clinicians should watch for worsening of symptoms and slowly titrate medications to avoid deterioration. Investigations like urinary copper levels and serum markers can provide information on treatment compliance and effectiveness, while repeat neuroimaging and clinical exams over time assess neurological recovery. Persisting tremors may require additional interventions like thalamotomy.
Wilsons disease and hepatitis dr. abhamoni baroSanjeev Kumar
Case: Prolonged acute hepatitis – is there more to it?
Presenter: Abhamoni Baro
Moderator: Ashish Bavdekar
Panelists: Prakash Vaidya, Harshad Devarbhavi, Seema Alam
DECLARATION OF HELSINKI - History and principlesanaghabharat01
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Mercurius is named after the roman god mercurius, the god of trade and science. The planet mercurius is named after the same god. Mercurius is sometimes called hydrargyrum, means ‘watery silver’. Its shine and colour are very similar to silver, but mercury is a fluid at room temperatures. The name quick silver is a translation of hydrargyrum, where the word quick describes its tendency to scatter away in all directions.
The droplets have a tendency to conglomerate to one big mass, but on being shaken they fall apart into countless little droplets again. It is used to ignite explosives, like mercury fulminate, the explosive character is one of its general themes.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
2. Cholestasis (Greek-bile stoppage)
Reduction or absence of bile flow into duodenum
Intrahepatic •Impairment of bile
secretion at the level of
bile ductules (ductular
cholestasis)
•Functional defect in
Extrahepatic bile formation at
hepatocyte level
(hepatocellular
Chronic if > 6mo duration chlestasis)
Etiology: differs across ages
Alkaline phosphatase >1.5ULN, GGT> 3ULN*
3. Neonatal cholestasis: metabolic etiology?
Metabolic etiology
Presenting as liver failure
West:2000-2006 Galactosemia
Tyrosinemia
N Haemachromatosis
Mitochondrial/FAOD
Nieman Pick C
HFI
Others
PFIC/ BASD
Cystic Fibrosis
AATD X
Citrin deficiency
Peroxisomal disorders (Zellweger)
Nieman Pick A, Wolmans disease
Cong Disorders Glycosylation
Gaucher’s etc
Clin Liver Dis 2006;10:27-53
9. F1C1/ ATP8B1 (18q 21-22)
• Lipid flippase transports phosphotidyl serine from exoplasmic to
cytoplasmic leaflet of canalicular membrane of hepatocyte.
• Less stable canalicular membrane leads to impaired BSEP function
• PFIC 1/ BRIC 1 and ICP
BSEP/ ABCB 11 ( 2q24)
• Primary transporter responsible for bile salt secretion
• PFIC 2/ BRIC 2/ ICP
MDR 3/ ABCB4 (7q 21)
• Canalicular phospholipid translocator causes excretion of
phosphatidyl choline in bile.
• Low PC in bile causes high biliary cholesterol saturation index
• PFIC3/ ICP/ LPAC/ transient neonatal cholestasis/ drug induced
cholestasis.
10. Progressive familial intrahepatic cholestasis
(PFIC)
• AR inheritance, three types 1-3
• Clues- consanguinity, cholestasis of pregnancy in
mother, affected sibling
• Pruritus, jaundice, hepato- splenomegaly, pigmented
stools
• Initial episodes of severe cholestasis followed by
disease-free intervals, but eventually it becomes non
remitting.
• Disease is typically progressive, leading to
cirrhosis/portal hypertension/ESLD and death
J Pediatr 2007;150:556-9 J Gastroenterol Hepatol 1999; 14: 594-99
11. PFIC 1 PFIC 2 PFIC 3
Onset First few mo First few mo Late infancy (~30%)/
Childhood/ adults
ESLD First decade rapid, first few years I-II decade
Extra hepatic Pancreatitis, diarrhea, none none
hearing loss, short
stature, Abn sweat
chloride
γGT N/ low N / low Raised
Liver biopsy Bland cholestasis Giant cell hepatitis, Bile ductular proli-
Hepatocellular necrosis, feration Inflammatory
portal fibrosis infiltrate, fibrosis
E microscopy Granular bile Amorphous bile -
AFP N increased N
Serum bile acids Raised ++ Raised ++ Raised +
Bile: Primary BS Reduced Severely reduced Normal
Biliary phospho- Normal Normal Reduced
lipids
12. PFIC1 and 2 : differentiation
Type I (n-61) Type II (n-84)
ALT/AST + ++ higher
Serum bile acids + ++ higher
Bx giant cells 7% 73% more
Gall stones no 32%
Portal hypertension less More
HCC no 4/84
Growth failure more less
Extrahepatic +++ no
Presentation similar
Type I is a multisystem disease
Type II more severe hepatobiliary disease/ gall stones/HCC/ cholangioCa
J Hepatol 2010;53:170-78// Hepatology 2010;51:1645-55
13. Immunostaining and PFIC
• BSEP and MDR3 antibodies used for immunostaining
• Absence of canalicular or mild immunostaining favors gene
defect
• Normal staining does not exclude gene defect as mutation
may induce loss of function but normal synthesis.
Normal `MDR3 staining no MDR 3 staining
Genetic testing “Gold standard” for diagnosis
Orphanet J of Rare Diseases 2009; 4:1-12
14. PFIC: management
Drug Low High Mechanism of action
C+ partial GGT GGT
response PFIC PFIC
UDCA 22+12 20+14 Replaces endogenous
More in type III cytotoxic BA
98 46
biliary PL/ total ~30% ~70% Induces expression of
lipids>7% predicts ABCB11/ABCB4
response
Rifampicin 0+3 - CYP3A4 induction, 6α
17 hydroxylation of BS and urinary
~16% excretion
Cholestyramine 0+0 2+2 Reduced reabsorption of BS in
34 16 intestine
~25% Stimulates fecal BS excretion
Complete-normalization of transmainases or/ bilirubin/relief of pruritus
Partial- some improvement J Hepatol 2010;52:258-71
15. PFIC and partial biliary diversion
Reduces enterohepatic circulation
External-
jejunal conduit between GB & skin stoma
Internal-
Ileocolonic anastomosis (ileal bypass)
Jejunal conduit between Gb and colon
- successful (LFT/ pruritus) in ~81% cases
- stops progression and even resolution
of histologic changes
- significant fibrosis/cirrhosis predicts failure
- choice between procedures? No RCT
- ensure fluid/electrolyte balance in PEBD
-Ileal
bypass-recurrence within 1y due to ileal adaptation
-Nasobiliary drainage may select responders to biliary diversion
Hep 2006;43:51-53, Clin liv Dis 2000;4:831-8/ J Ped surg 2009;44:821-27/
Ped Surg Int 2010;26:831-34/ Hepatol 2006;43:51-53
17. PFIC and Liver Transplantation
• Reserved for patients with ESLD/ no response to other
therapy
• Survival rate 75-100% (similar to EHBA)
• Guarded prognosis in type1,diarrhea may worsen after
transplant when biliary bile salt secretion is restored with
severe hepatic steatosis
HCC monitoring should be done
from 1st year of life especially in PFIC2
Pediatr Transplant 2006;10:570-74/ 2007;11:634-40// liver transpl 2002;8:714-16/ 2009;15:610-18
18. Benign recurrent intrahepatic cholestasis
(BRIC)
• Recurrent attacks of jaundice, pruritus, steatorrhoea and ± wt loss
• Pruritus precedes jaundice (diff AVH)
• Each attack 2wk-18mo, mean ~3mo
• Improvement in appetite heralds resolution of attack
• Asymptomatic period b/w attacks 1mo-30y, average once every 2y
• Attacks start mostly before 20y of age
• Most cases sporadic, family history in upto 50%
• No progression to CLD
• Attacks often precipitated by acute gastroenteritis.
• Factors causing onset and resolution of cholestatic event ? unclear.
Infection---related endotoxemia----post transcriptional down
regulation of human BSEP
Ann Hepatol 2010;9:207-10, Gastroenterol 2004;127:379-84
19. • Prototype is BRIC 1 (ATP8B1), BRIC 2 and 3 also described
• Location of mutation determines presentation as PFIC 1 or BRIC 1
• Mutation in highly conserved portion in PFIC I and non conserved area
which encodes for non critical portion of the FIC1 protein in BRIC 1
20. BRIC: treatment
• Correction of coagulopathy if any
• Symptomatic treatment of pruritus-
rifampicin, cholestyramine, UDCA, naltrexone
• Nasobiliary drainage-
effect within 24-48hrs, response in 7/9cases*
Drugs may be tried for 4-8wks to assess response
• Plasmapheresis
• MARS important in refractory cases**
• Liver transplantation??
Hepatol 2006;43;51-53*// Eur J Gast Hep 2005;17:585-8**
21. Intrahepatic cholestasis of pregnancy
Pathogenesis- mutation in BSEP/MDR3,
- higher estrogen and progesterone metabolites
Higher incidence is seen in twin pregnancies (20%-22%)
Late II-III trimester pruritus with mild jaundice
Pruritus affects the palms and soles and worsens at night
Constitutional symptoms: anorexia, malaise, abdominal pain
Pale stools, dark urine and steatorrhea may occur
Mild increase in ALT/AST, normal to raised GGT
Raised serum bile acids >10 µmol/L (gold standard)
Symptoms resolve within 48 h and biochemical abnormalities within 2-
8 wk of delivery.
Recurs in subsequent pregnancy or with OCP
Sem Liv dis 2010;30:134-46/Hepatology 2004;40:467e74
/Postgrad Med J 2010;86:160e164 / WJG 2009 ; 15: 2049-2066
22. Foetal complications
• Sudden IUD 3.5%, meconium stained liquor 16-50% ,
preterm labour 30-40%
• risk of adverse fetal outcomes increases with increasing
levels of maternal serum bile acids
Management:
• UDCA, effective in 70-80%, safe,
• Target fasting BA <40 µmol/L
• Vitamin K
• Topical treatment with aqueous cream with 2% menthol
• Elective delivery at 37wk pregnancy as most IUD occur
at/after 37wks
23. Bile acid synthesis defects
• Uncommon, ~2% of liver disease in infancy
• Nine defects identified.
• Commonest 3 beta hydroxy delta 5 C27steroid
dehydrogenase def (AR)
• Commonest presentation with neonatal cholestasis
• Most present with jaundice, hepatomegaly, steatorrhea ,
FTT , vitamin ADEK deficiency in first 3y of life
• Untreated cirrhosis and ESLD by 5y of age
JPGN 2010;50:61-66
24. Diagnosis:
• N GGT, reduced serum bile acids
• ALT/AST/ blirubin raised, low plasma cholesterol
• Liver biopsy giant cell hepatitis, steatosis
• Abnormal BA in urine by FAB-MS (fast atom bombardment mass
spectrometry) or ESLMS (electrospray ionisation tandem mass
spectrometry)
UDCA interferes with detection of abnormal BA so should be
stopped 5days before testing
• Skin biopsy-fibroblast culture and enzyme estimation
Treatment:
• Chenodeoxy cholic acid with/ without cholic acid
• Monitor by amount of abnormal BA in urine
• Excellent response with improvement in histology
J Inherit Metab dis 2011;34:593-604
25. Cystic fibrosis
• Accounts ~0.7% of NCS
• Presents at 1-2mo age, jaundice, hepatosplenomegaly, pale stools,
• h/p portal expansion, periportal steatosis, biliary proliferation
• Jaundice clears in majority by 7-8mo of age, few patients
progress to overt CLD
• ~30% have CF associated liver disease: fatty liver, focal/
multilobular biliary cirrhosis
• Meconium ileus, use of TPN, pancreatic insufficiency, severe
genotype, and males have increased risk of liver disease
• Diagnosis:
sweat chloride, genetic testing
• Treatment:
UDCA, supportive,
liver transplantation
JPGN 2006;43:s49-55/ Arch Dis Child 1999;81:125–128
26. Approach to cholestasis
step I: Differentiate extrahepatic and intrahepatic
history, physical examination and imaging
(USG/ CT, ERCP, MRCP, EUS)
intra hepatic extra hepatic
Evaluate as per cause
GGT
HIGH
LOW/ NORMAL
PFIC I/II BASD Pruritus +nt -nt
PFIC III Cyst Fibrosis
Pruritus +++ ±
AATD citrin def
Serum BA raised normal/low
Alagille synd others
Liver biopsy
28. Conclusions
• Long list of metabolic causes of cholestasis
• Early identification of the treatable conditions is
a priority
• “Pattern of presentation” helps in making the
differential diagnosis
• Team approach of pediatrician, geneticist,
gastroenterologist and good metabolic lab
crucial for diagnosis and management